Neuralink
Neurotech & Neuromodulation · Medical & Healthcare Robotics

Neuralink: Funding & valuation

Funds reporting to the SEC (1) valued their Neuralink stock at $5M as of Jun 2026.

Data updated Nov 22, 2026 · Back to the company report

Financials

Funding rounds, investors and revenue on record.

$1.1BTotal raised
Series ELatest round
3Rounds and grants4 investors
Money by yearUSD, rounds and grants
2025$650M1 record
2023$280M1 record
2021$205M1 record
Largest rounds and grants
Series E
2025
$650M
Series D
2023
$280M
Series C
2021
$205M
Sources: funding announcements, grant and company registers

Money

Funds reporting to the SEC (1) valued their Neuralink stock at $5M as of Jun 2026.

Fund markswhat funds reporting to the SEC say their stakes are worth
Price a share in fund marks, by quarter
Jun 2026median of 1 marks · sec.gov ↗$50.50
Mar 2026median of 1 marks · sec.gov ↗$50.50
Dec 2025median of 1 marks · sec.gov ↗$50.50
Marks by fund: shares held, the price a share, the change since the last quarterPremiumUnlockor this company alone for 30 days · 50 credits
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".